Epoxide Hydrolase: A Potential Drug Target Or Biomarker (P10611)

Target Name: Epoxide Hydrolase

NCBI ID: P10611

Epoxide Hydrolase

Other Name(s): None

Epoxide Hydrolase: A Potential Drug Target Or Biomarker

Epoxide Hydrolase (nonspecific subtype), also known as 2-oxoglutarate dehydrogenase (2-OGDH), is a enzyme involved in the cellular metabolism of 2-oxoglutarate (2-OG) to carbon dioxide and water. 2-OGDH is a key enzyme in the citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA) cycle, which is a central metabolic pathway that generates energy in the form of ATP from food inputs.

Epoxide Hydrolase is a transmembrane protein that is located at the endoplasmic reticulum (ER) and is involved in the final step of the 2-OGDH cycle, which is the production of carbon dioxide as a byproduct of the reaction. The 2-OGDH cycle is a critical pathway for the production of ATP in the cell, and epoxide hydrolase is a key enzyme that enables the production of ATP from 2-OG.

The 2-OGDH cycle is also involved in the production of other important molecules, including carbonate and glutamyl acids, which have important roles in cellular signaling and signaling pathways. The 2-OGDH cycle is also involved in the production of aromatic amino acids, which are important for the production of important signaling molecules, such as angiotensin and thromboxane.

Epoxide Hydrolase is a protein that is expressed in most tissues of the body and is involved in the 2-OGDH cycle in a variety of cell types. It is a key enzyme in the production of ATP and other molecules that are important for cellular signaling and metabolism.

Due to its involvement in the production of ATP and other molecules, epoxide hydrolase is of interest as a potential drug target or biomarker. Activating the 2-OGDH cycle has been shown to have a variety of effects on cellular behavior and metabolism, including the production of ATP, the regulation of cellular signaling pathways, and the production of important molecules such as carbonate and glutamyl acids.

In addition, epoxide hydrolase is also involved in the production of aromatic amino acids, which are important for the production of important signaling molecules. The production of aromatic amino acids by the 2-OGDH cycle has been shown to play a role in the regulation of cellular signaling pathways and in the development of certain diseases, such as cancer.

Furthermore, the 2-OGDH cycle is also involved in the production of carbonate and glutamyl acids, which have important roles in cellular signaling and signaling pathways. The production of carbonate and glutamyl acids by the 2-OGDH cycle has been shown to play a role in the regulation of cellular signaling pathways and in the development of certain diseases, such as cancer.

In conclusion, epoxide hydrolase is a protein that is involved in the production of ATP and other molecules important for cellular signaling and metabolism. Its involvement in the 2-OGDH cycle makes it of interest as a potential drug target or biomarker. Further research is needed to fully understand the role of epoxide hydrolase in cellular signaling and metabolism, and to determine its potential as a drug target or biomarker.

Protein Name: Epoxide Hydrolase (nonspecified Subtype)

The "Epoxide Hydrolase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Epoxide Hydrolase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets